Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It transforms the drug discovery process with a focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-2608, a...
5 insider purchases on record · latest filing 2020-07-21.
Insiders have also filed 273 sale transactions at RLAY.